Promising Clinical Trial Results Reinforce Buy Rating for Viracta Therapeutics

2d ago, source:

Leerink Partners analyst Andrew Berens has maintained their bullish stance on VIRX stock, giving a Buy rating yesterday. Andrew Berens has ...

Peter J Barris's Net Worth

8d ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include GLU MOBILE INC, SUNESIS PHARMACEUTICALS INC, MOTRICITY INC, SOURCEFIRE INC, BOINGO WIRELESS INC, AUDIENCE INC, PEPLIN INC ...

IBT Staff Reporter

21d ago, source: International Business Times

Sunesis Pharma shares up for 2nd day on data, partnership talks Shares of Sunesis Pharmaceuticals Inc (SNSS.O) were up for the second day on Friday, after positive data from two clinical trials of ...

Form 8-K - Current report

1mon ago, source: ADVFN

Inc. (f/k/a Sunesis Pharmaceuticals, Inc.) (“Viracta”). As part of the amendment, the Company will make a one-time payment in March 2024 to Viracta of $5 million in exchange for reduced ...

ABOS Acumen Pharmaceuticals, Inc.

7h ago, source: Seeking Alpha

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted ...

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC's Net Worth

28d ago, source: Benzinga.com

Who is ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC? ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC has an estimated net worth of $134 Million. This is based on reported shares across multiple ...

Acurx Pharmaceuticals, Inc. (ACXP)

1d ago, source: Yahoo Finance

Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the ...

VIRX Viracta Therapeutics, Inc.

4d ago, source: Seeking Alpha

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product ...

Elite Pharmaceuticals, Inc. (ELTP)

1d ago, source: Yahoo Finance

Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript February 15, 2024 Elite Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Vertex Pharmaceuticals Inc VRTX

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Madrigal Pharmaceuticals Inc MDGL

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...